SG Americas Securities LLC Cuts Position in Chemed Co. (NYSE:CHE)

SG Americas Securities LLC trimmed its holdings in Chemed Co. (NYSE:CHE) by 93.5% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 489 shares of the company’s stock after selling 7,062 shares during the quarter. SG Americas Securities LLC’s holdings in Chemed were worth $294,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Thrivent Financial for Lutherans lifted its holdings in shares of Chemed by 300.3% during the second quarter. Thrivent Financial for Lutherans now owns 116,572 shares of the company’s stock worth $63,249,000 after purchasing an additional 87,449 shares during the period. Impax Asset Management Group plc boosted its stake in Chemed by 19.5% in the 2nd quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock worth $172,510,000 after buying an additional 51,974 shares during the last quarter. ProShare Advisors LLC grew its holdings in shares of Chemed by 6,288.9% during the 1st quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock worth $32,482,000 after purchasing an additional 49,808 shares during the period. TD Asset Management Inc lifted its position in Chemed by 23.9% during the 1st quarter. TD Asset Management Inc now owns 254,953 shares of the company’s stock worth $163,662,000 after acquiring an additional 49,176 shares in the last quarter. Finally, Acadian Asset Management LLC raised its position in shares of Chemed by 29.3% in the 1st quarter. Acadian Asset Management LLC now owns 179,465 shares of the company’s stock valued at $115,184,000 after purchasing an additional 40,695 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Chemed Stock Down 0.4 %

Shares of CHE opened at $610.18 on Friday. The business’s 50 day moving average is $583.81 and its two-hundred day moving average is $570.84. Chemed Co. has a 52-week low of $502.64 and a 52-week high of $654.62. The firm has a market cap of $9.24 billion, a price-to-earnings ratio of 32.84, a PEG ratio of 2.44 and a beta of 0.44.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The company had revenue of $595.88 million for the quarter, compared to the consensus estimate of $599.20 million. During the same quarter in the previous year, the company earned $4.71 earnings per share. Chemed’s quarterly revenue was up 7.6% compared to the same quarter last year. On average, equities analysts expect that Chemed Co. will post 21.77 earnings per share for the current fiscal year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were paid a $0.50 dividend. This is an increase from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 0.33%. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s dividend payout ratio is currently 10.76%.

Insider Buying and Selling

In related news, Director George J. Walsh III sold 200 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the sale, the director now directly owns 3,446 shares of the company’s stock, valued at approximately $1,991,615.70. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the sale, the executive vice president now owns 5,990 shares of the company’s stock, valued at $3,363,864.20. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director George J. Walsh III sold 200 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the sale, the director now directly owns 3,446 shares in the company, valued at $1,991,615.70. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 9,144 shares of company stock valued at $5,264,839. Corporate insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.